
About Paul Ehrlich Institute
Paul Ehrlich Institute is a Healthcare company based in Langen (Germany) founded in 1896. Drug research, development, pharmacovigilance, and regulatory support are provided. Its website pei.de draws about 132 thousand monthly visits. Paul Ehrlich Institute offers products and services including Vaccine Testing, Pharmaceutical Regulation, and Batch Prüfung. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity is Paul-Ehrlich-Institut.
Company details
The Paul Ehrlich Institute was established in 1896 and is based in Langen, Germany. Operations are centered on the pharmaceutical and biomedical sectors, where drug research and development are conducted alongside pharmacovigilance monitoring. Regulatory support services are extended to ensure compliance and safety in vaccine and biomedicine fields. Expertise is applied through federal oversight, focusing on public health standards across European contexts.
- Headquarters Langen, Germany
- SectorsHealthcare
- Website category Health · Pharmacy
- Website pei.de/DE/home/home-node.html
- Legal Name Paul-Ehrlich-Institut
- Investors
Products & Services of Paul Ehrlich Institute
Paul Ehrlich Institute offers a comprehensive portfolio of products and services, including Vaccine Testing, Pharmaceutical Regulation, and Batch Prüfung.
Tests vaccines for quality, efficacy, and safety standards.
Monitors and approves medicines for public health compliance.
Evaluates drug batches for regulatory adherence and safety.
Funding Insights of Paul Ehrlich Institute
- Total Rounds 5
- First Round $411,826
(Jan 2018)
- Investors Count 1
All 5 funding rounds of Paul Ehrlich Institute with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | Grant | – | – | ||
| Feb 2021 | Grant | – | – | ||
| Mar 2020 | $558,772 | Grant | – | – | |
| May 2018 | $275,268 | Grant | – | – | |
| Jan 2018 | $411,826 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Paul Ehrlich Institute
Paul Ehrlich Institute has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Paul Ehrlich Institute
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Paul Ehrlich Institute
3 dated milestones of Paul Ehrlich Institute across 127 years, from founding to its latest funding, stage changes and deals.
- Founded Paul Ehrlich Institute is founded.
- Funding First funding round of $412K.
- Funding Latest funding round, Grant,.
Web traffic of Paul Ehrlich Institute
The website of Paul Ehrlich Institute (pei.de) receives about 132.3K visits a month and ranks #350,606 among all websites worldwide, #661 in Pharmacy.
- Monthly visits132.3K
▲ 6.8% vs previous month
- Unique visitors69.7K
per month
- Global rank#350,606
among all websites
- Category rank#661
Health · Pharmacy
- Bounce rate47%
- Pages per visit1.7
- Average visit31 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with Paul Ehrlich Institute. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
apotheke-adhoc.de | apotheke-adhoc.de | 100% | #29,969 | – | |
portal.dimdi.de | portal.dimdi.de | 94% | – | ||
| rki.de | 92% | 911.4K | #68,633 | View details | |
| gelbe-liste.de | 90% | #27,850 | View details | ||
fachinfo.de | fachinfo.de | 85% | #186,542 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Paul Ehrlich Institute
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Paul Ehrlich Institute
Paul Ehrlich Institute was founded in 1896 and raised its 1st funding round 122 years after it was founded.
Paul Ehrlich Institute is headquartered in Langen, Germany. It is registered at Langen, Hesse, Germany.
The Paul Ehrlich Institute was established in 1896 and is based in Langen, Germany. Operations are centered on the pharmaceutical and biomedical sectors, where drug research and development are conducted alongside pharmacovigilance monitoring. Regulatory support services are extended to ensure compliance and safety in vaccine and biomedicine fields. Expertise is applied through federal oversight, focusing on public health standards across European contexts.
Paul Ehrlich Institute offers Vaccine Testing, Pharmaceutical Regulation, and Batch Prüfung.
Paul Ehrlich Institute has 1 investor. Key investors include European Union.
Paul Ehrlich Institute operates through Paul-Ehrlich-Institut.
The website of Paul Ehrlich Institute receives about 132 thousand visits a month and ranks #350,606 among all websites worldwide.